Duvaud, Lauriane

Profilbild
E-Mail-Adresse
Geburtsdatum
Projekt
Organisationseinheiten
Berufsbeschreibung
Nachname
Duvaud
Vorname
Lauriane
Name
Lauriane Duvaud

Filter

20241

Einstellungen

Suchergebnisse

Gerade angezeigt 1 - 1 von 1
  • Kein Vorschaubild vorhanden
    Publikation
    Bryophyllum pinnatum inhibits oxytocin and vasopressin signaling in myometrial cells
    (Thieme, 10.04.2024) Zurfluh, Leonie; Duvaud, Lauriane; Inci, Nejla; Potterat, Olivier; Simões-Wüst, Ana Paula; Mosbacher, Johannes
    The medicinal plant Bryophyllum pinnatum was previously shown to block oxytocin (OT)-induced signals in myometrial cells, consistent with its tocolytic effect observed in patients. OT activates not only OT receptors but also V 1A receptors, two receptors with high receptor homology that are both expressed in the myometrium and play a crucial role in myometrial contraction signaling. We aimed to study the molecular pharmacology of B. pinnatum herbal preparations using specific receptor ligands, the human myometrial cell line hTERT‑C3, and cell lines expressing recombinant human OT and V 1A receptors. We found that press juice from B. pinnatum (BPJ) inhibits both OT- and vasopressin (AVP)-induced intracellular calcium increases in hTERT‑C3 myometrial cells. In additional assays performed with cells expressing recombinant receptors, BPJ also inhibited OT and V 1A receptor-mediated signals with a similar potency (IC 50 about 0.5 mg/mL). We further studied endogenous OT- and AVP-sensitive receptors in hTERT‑C3 cells and found that OT and AVP stimulated those receptors with similar potency (EC50 of ~ 1 nM), suggesting expression of both receptor subtypes. This interpretation was corroborated by the antagonist potencies of atosiban and relcovaptan that we found. However, using qPCR, we almost exclusively found expression of OT receptors suggesting a pharmacological difference between recombinant OT receptors and native receptors expressed in hTERT‑C3 cells. In conclusion, we show that B. pinnatum inhibits both OT and AVP signaling, which may point beyond its tocolytic effects to other indications involving a disbalance in the vasopressinergic system.
    01A - Beitrag in wissenschaftlicher Zeitschrift